Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

nfections." Greece, Poland, Germany, Denmark, and Portugal all posted new daily records, as well. EFTA00135825 The New York Timec (10/22, McCann, Leatherby, 18.61M) reports that in Europe, "a second wave of serious illness is here, new data released on Thursday shows, making it clear that the pandemic

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

aily records, as well. The New York Times <https://www.nytimes.com/interactive/2020/10/22/world/europe/europe-hospitals- covid.html> (10/22, McCann, Leatherby, 18.61M) reports that in Europe, "a second wave of serious illness is here, new data released on Thursday shows, making it clear that the pandemic i

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ecord rise in infections." Greece, Poland, Germany, Denmark, and Portugal all posted new daily records, as well. The New York Times (10/22, McCann, Leatherby, 18.61M) reports that in Europe, "a second wave of serious illness is here, new data released on Thursday shows, making it clear that the pandemic